Valeant CEO Mike Pearson Has to Explain His Price Hiking Strategy to the Senate
Michael Pearson, CEO of Canadian pharmaceutical company Valeant, will give his testimony before the Senate on Wednesday regarding his price hiking strategy. Meanwhile, Valeant has appointed a new CEO to replace him.